Also trades as: 4540.T (JPX) · $vol 9M

$23.20

+0.00 (+0.00%)

OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 46 · $1.7B mcap · 57M float · 0.0001% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$193.8B +7.0% ▲

5Y CAGR: +10.7%

Gross Profit

$92.1B +1.7% ▲

5Y CAGR: +8.8%

Operating Income

$35.4B -11.7% ▼

5Y CAGR: +12.8%

Net Income

$28.3B -12.7% ▼

5Y CAGR: +13.0%

EPS (Diluted)

$378.68 -11.3% ▼

5Y CAGR: +13.6%

EBITDA

$48.6B -15.1% ▼

5Y CAGR: +11.7%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$129.5B	$140.0B	$150.8B	$181.1B	$193.8B
YoY Growth	+11.3%	+8.1%	+7.7%	+20.1%	+7.0%
Cost of Revenue	$63.1B	$71.8B	$82.0B	$90.5B	$101.7B
Gross Profit	$66.5B	$68.3B	$68.8B	$90.6B	$92.1B
Gross Margin	51.3%	48.8%	45.6%	50.0%	47.5%
R&D Expenses	$7.3B	$7.6B	$8.3B	$0	$0
SG&A Expenses	$36.8B	$39.8B	$40.5B	$50.5B	$56.7B
Operating Expenses	$44.1B	$47.4B	$48.8B	$50.5B	$56.7B
Operating Income	$22.4B	$20.9B	$20.0B	$40.1B	$35.4B
Operating Margin	17.3%	14.9%	13.3%	22.2%	18.3%
Interest Expense	$173M	$256M	$330M	$518M	$1.1B
Income Before Tax	$25.6B	$23.0B	$23.7B	$45.6B	$41.3B
Tax Expense	$6.2B	$5.6B	$5.7B	$11.0B	$10.9B
Net Income	$18.8B	$16.5B	$16.7B	$32.4B	$28.3B
Net Margin	14.5%	11.8%	11.1%	17.9%	14.6%
EPS (Diluted)	$246.21	$215.63	$219.82	$427.15	$378.68
EBITDA	$31.6B	$33.9B	$34.8B	$57.2B	$48.6B
Shares Outstanding	77M	76M	76M	76M	75M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$43.7B	$45.4B	$47.7B	$44.3B	$43.1B	$47.5B	$55.3B	$47.7B
Cost of Revenue	$20.9B	$22.3B	$23.8B	$23.5B	$22.6B	$24.2B	$29.4B	$25.5B
Gross Profit	$22.8B	$23.0B	$23.9B	$20.8B	$20.5B	$23.3B	$26.0B	$22.2B
Gross Margin	52.3%	50.8%	50.2%	46.9%	47.6%	49.1%	46.9%	46.6%
R&D Expenses	$0	$0	$0	$8.4B	$0	$0	$0	$0
SG&A Expenses	$12.3B	$12.5B	$12.6B	$13.0B	$12.8B	$13.8B	$14.2B	$15.8B
Operating Expenses	$12.3B	$12.5B	$12.6B	$13.0B	$12.8B	$13.8B	$14.2B	$15.8B
Operating Income	$10.6B	$10.5B	$11.3B	$7.7B	$7.7B	$9.5B	$11.8B	$6.4B
Operating Margin	24.2%	23.1%	23.7%	17.5%	17.9%	20.1%	21.2%	13.4%
Interest Expense	$0	$0	$0	$953K	$1M	$202M	$273M	$436M
Income Before Tax	$15.8B	$9.3B	$12.8B	$7.6B	$6.2B	$11.9B	$15.4B	$7.9B
Tax Expense	$4.4B	$2.0B	$3.4B	$1.2B	$1.7B	$3.2B	$4.2B	$1.7B
Net Income	$11.2B	$6.3B	$9.1B	$5.9B	$4.4B	$8.2B	$10.7B	$5.0B
Net Margin	25.6%	13.9%	19.0%	13.2%	10.1%	17.3%	19.3%	10.5%
EPS (Diluted)	$147.24	$83.26	$119.37	$77.24	$58.15	$111.00	$143.31	$67.11
EBITDA	$13.4B	$13.3B	$14.0B	$10.6B	$10.7B	$15.1B	$19.1B	$10.1B
Shares Outstanding	76M	76M	76M	76M	75M	74M	75M	74M

TSMRF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet